Matt has published 65 peer-reviewed papers in the past five years alone. His work has significantly advanced our understanding of how the fetus responds to infectious and inflammatory insults, how susceptibility to infection changes with gestation, and how common prematurity-associated infections can be targeted with antibiotic agents.
Working with collaborators in the United States, his antenatal steroids studies have shown that current dosing strategies are likely excessive and demonstrated how modulated dosing can be used to deliver optimal preterm lung maturation.
Working in collaborators in Japan, Matt’s studies with the artificial uterine life support platform for extremely preterm infants have generated national and international interest and are presently in an advanced phase of pre-clinical development.
Matt also maintains an active interest in higher education, and has made a significant contribution to the empirical-based development of learning systems in doctoral education.